An increased expression profile of Th9/IL-9 correlated with Th17/IL-17 in patients with immune thrombocytopenia

References

• Neunert CE. Current management of immune thrombocytopenia. Hematology Am Soc Hematol Educ Program 2013;2013:276–282.
   PubMed Web of Science ®Google Scholar
• Cines DB, Cuker A, Semple JW. Pathogenesis of immune thrombocytopenia. Presse Med 2014;43:e49–e59.
   PubMedGoogle Scholar
• McKenzie CG, Guo L, Freedman J, Semple JW. Cellular immune dysfunction in immune thrombocytopenia (ITP). Br J Haematol 2013;163:10–23.
   PubMed Web of Science ®Google Scholar
• Ji X, Zhang L, Peng J, Hou M. T cell immune abnormalities in immune thrombocytopenia. J Hematol Oncol 2014;7:72.
   PubMed Web of Science ®Google Scholar
• Johnsen J. Pathogenesis in immune thrombocytopenia: new insights. Hematology Am Soc Hematol Educ Program 2012;2012:306–312.
   PubMed Web of Science ®Google Scholar
• Ma L, Zhou Z, Zhang D, Wang H, Li H, Xue F, Yang R. Bmi-1 regulates autoreactive CD4+ T cell survival in immune thrombocytopenia patients. J Clin Immunol 2012;32:505–513.
   PubMed Web of Science ®Google Scholar
• Raphael I, Nalawade S, Eagar TN, Forsthuber TG. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 2015;74:5–17.
   PubMed Web of Science ®Google Scholar
• Smith KM, Pottage L, Thomas ER, Leishman AJ, Doig TN, Xu D, Liew FY, Garside P. Th1 and Th2 CD4+ T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo. J Immunol 2000;165:3136–3144.
   PubMed Web of Science ®Google Scholar
• Ogawara H, Handa H, Morita K, Hayakawa M, Kojima J, Amagai H, Tsumita Y, Kaneko Y, Tsukamoto N, Nojima Y, et al. High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura. Eur J Haematol 2003;71:283–288.
   PubMed Web of Science ®Google Scholar
• Wang T, Zhao H, Ren H, Guo J, Xu M, Yang R, Han ZC. Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura. Haematologica 2005;90:914–923.
   PubMed Web of Science ®Google Scholar
• Zhou L, Xu F, Chang C, Tao Y, Song L, Li X. Interleukin-17-producing CD4+ T lymphocytes are increased in the patients with primary immune thrombocytopenia. Blood Coagul Fibrinolysis 2016;27:301–307.
   PubMed Web of Science ®Google Scholar
• Rocha AM, Souza C, Rocha GA, de Melo FF, Clementino NC, Marino MC, Bozzi A, Silva ML, Martins Filho OA, Queiroz DM. The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia. Haematologica 2011;96:1560–1564.
   PubMed Web of Science ®Google Scholar
• Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA, Mitsdoerffer M, Strom TB, Elyaman W, Ho IC, et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 2008;9:1347–1355.
   PubMed Web of Science ®Google Scholar
• Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, Buer J, Martin B, Wilhelm C, Stockinger B. Transforming growth factor-beta ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008;9:1341–1346.
   PubMed Web of Science ®Google Scholar
• Chang HC, Sehra S, Goswami R, Yao W, Yu Q, Stritesky GL, Jabeen R, McKinley C, Ahyi AN, Han L, et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 2010;11:527–534.
   PubMed Web of Science ®Google Scholar
• Staudt V, Bothur E, Klein M, Lingnau K, Reuter S, Grebe N, Gerlitzki B, Hoffmann M, Ulges A, Taube C, et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 2010;33:192–202.
   PubMed Web of Science ®Google Scholar
• Jabeen R, Goswami R, Awe O, Kulkarni A, Nguyen ET, Attenasio A, Walsh D, Olson MR, Kim MH, Tepper RS, et al. Th9 cell development requires a BATF-regulated transcriptional network. J Clin Invest 2013;123:4641–4653.
   PubMed Web of Science ®Google Scholar
• Kaplan MH. Th9 cells: differentiation and disease. Immunol Rev 2013;252:104–115.
   PubMed Web of Science ®Google Scholar
• Schmitt E, Klein M, Bopp T. Th9 cells, new players in adaptive immunity. Trends Immunol 2014;35:61–68.
   PubMed Web of Science ®Google Scholar
• Jager A, Dardalhon V, Sobel RA, Bettelli E, Kuchroo VK. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 2009;183:7169–7177.
   PubMed Web of Science ®Google Scholar
• Vegran F, Apetoh L, Ghiringhelli F. Th9 cells: a novel CD4 T-cell subset in the immune war against cancer. Cancer Res 2015;75:475–479.
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009;113:2386–2393.
   Google Scholar
• Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115:168–186.
   Google Scholar
• Qiao J, Liu Y, Li D, Wu Y, Li X, Yao Y, Niu M, Fu C, Li H, Ma P, et al. Imbalanced expression of Bcl-xL and Bax in platelets treated with plasma from immune thrombocytopenia. Immunol Res 2016;64:604–609.
   PubMed Web of Science ®Google Scholar
• Qiao J, Liu Y, Li X, Xia Y, Wu Y, Li D, Li H, Ma P, Zhu F, Li Z, et al. Elevated expression of NLRP3 in patients with immune thrombocytopenia. Immunol Res 2016;64:431–437.
   PubMed Web of Science ®Google Scholar
• Zhou L, Littman DR. Transcriptional regulatory networks in Th17 cell differentiation. Curr Opin Immunol 2009;21:146–152.
   PubMed Web of Science ®Google Scholar
• Pan HF, Leng RX, Li XP, Zheng SG, Ye DQ. Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases. Cytokine Growth Factor Rev 2013;24:515–522.
   PubMed Web of Science ®Google Scholar
• Jabeen R, Kaplan MH. The symphony of the ninth: the development and function of Th9 cells. Curr Opin Immunol 2012;24:303–307.
   PubMed Web of Science ®Google Scholar
• Jones CP, Gregory LG, Causton B, Campbell GA, Lloyd CM. Activin A and TGF-beta promote T(H)9 cell-mediated pulmonary allergic pathology. J Allergy Clin Immunol 2012;129:1000–1010e1003.
   Google Scholar
• Jia L, Wu C. Differentiation, regulation and function of Th9 cells. Adv Exp Med Biol 2014;841:181–207.
   PubMed Web of Science ®Google Scholar
• Goswami R, Kaplan MH. A brief history of IL-9. J Immunol 2011;186:3283–3288.
   PubMed Web of Science ®Google Scholar
• Knoops L, Louahed J, Renauld JC. IL-9-induced expansion of B-1b cells restores numbers but not function of B-1 lymphocytes in xid mice. J Immunol 2004;172:6101–6106.
   PubMed Web of Science ®Google Scholar
• Dugas B, Renauld JC, Pene J, Bonnefoy JY, Peti-Frere C, Braquet P, Bousquet J, Van Snick J, Mencia-Huerta JM. Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol 1993;23:1687–1692.
   PubMed Web of Science ®Google Scholar
• Locksley RM. Nine lives: plasticity among T helper cell subsets. J Exp Med 2009;206:1643–1646.
   PubMed Web of Science ®Google Scholar
• Nowak EC, Weaver CT, Turner H, Begum-Haque S, Becher B, Schreiner B, Coyle AJ, Kasper LH, Noelle RJ. IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med 2009;206:1653–1660.
   PubMed Web of Science ®Google Scholar
• Li H, Nourbakhsh B, Ciric B, Zhang GX, Rostami A. Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population. J Immunol 2010;185:4095–4100.
   PubMed Web of Science ®Google Scholar
• Singh TP, Schon MP, Wallbrecht K, Gruber-Wackernagel A, Wang XJ, Wolf P. Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis. PLoS One 2013;8:e51752.
   PubMed Web of Science ®Google Scholar
• Ciofani M, Madar A, Galan C, Sellars M, Mace K, Pauli F, Agarwal A, Huang W, Parkurst CN, Muratet M, et al. A validated regulatory network for Th17 cell specification. Cell 2012;151:289–303.
   PubMed Web of Science ®Google Scholar